Provigate, Inc.
PrivateLast Round
Grant
Oct 28, 2024
Total Funding Raised
$13.33M
Company Overview
Provigate, Inc. is a healthcare technology company that develops non-invasive blood glucose monitoring sensors, devices, and digital health applications to support diabetes prevention and management.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Telemedicine, Sensors, Patient Engagement
Business Model
B2B
Customer Profile
Services & Consulting, Hardware + Subscription
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Provigate, Inc. Comparables
Compare Provigate, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Epinex Diagnostics, Inc. | 77% | |
| Orange Biomed | 66% | |
| Roche Holding | 64% |
Provigate, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 28, 2024 | ||||
| Series B | Oct 28, 2024 | ||||
| VC Round | Jan 18, 2022 | ||||
| Strategic | Jan 18, 2022 | ||||
| VC Round | Sep 27, 2021 | ||||
Grant | Jul 29, 2021 |
Provigate, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tokyo Metropolitan Small and Medium Enterprise Support Center | Grant |
| Daikin Industries | VC Round |
| New Energy and Industrial Technology Development Organization | Grant |
| ANRI株式会社 | VC Round |
| Coral Capital | VC Round |
| Japan Science and Technology Agency | Series B, VC Round |
| SPARX Group | Series B, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 290% MoM to 5.6K.
- Nov 7, 2025
CEO to speak at the 65th Annual Meeting of the Japanese Society of Clinical Chemistry.
Provigate, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Provigate, Inc.'s valuation, stock price, and market status.
Is Provigate, Inc. a public or private company?
Provigate, Inc. is a private company.
What is the current stock price of Provigate, Inc.?
Provigate, Inc. is a private company, so its shares have no public market price. Caplight tracks Provigate, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Provigate, Inc. worth (valuation)?
Valuation information for Provigate, Inc. is not publicly available.
Can I buy Provigate, Inc. stock?
Provigate, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Provigate, Inc.'s last funding round?
Provigate, Inc.'s most recent funding round was Grant on October 28, 2024.
Who are the main investors in Provigate, Inc.?
Key investors in Provigate, Inc. include Tokyo Metropolitan Small and Medium Enterprise Support Center, Daikin Industries, New Energy and Industrial Technology Development Organization, ANRI株式会社, Coral Capital.
Will Provigate, Inc. IPO soon?
No public IPO plans have been announced for Provigate, Inc..
How can I track Provigate, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Provigate, Inc.'s shares on secondary markets.